Filing Details

Accession Number:
0000059478-15-000080
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-06 10:06:58
Reporting Period:
2015-02-04
Filing Date:
2015-02-06
Accepted Time:
2015-02-06 10:06:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538604 A David Ricks Lilly Corporate Center
Indianapolis IN 46285
Svp And Pres, Lilly Bio-Meds No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-04 3,147 $69.99 60,138 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,662 Indirect 401(k)
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2014.
  2. This transaction was executed in multiple trades at prices ranging from $69.80 to $70.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.